18-12463485-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001128626.2(SPIRE1):āc.1504A>Gā(p.Lys502Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,612,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001128626.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPIRE1 | NM_001128626.2 | c.1504A>G | p.Lys502Glu | missense_variant | 12/17 | ENST00000409402.9 | NP_001122098.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPIRE1 | ENST00000409402.9 | c.1504A>G | p.Lys502Glu | missense_variant | 12/17 | 1 | NM_001128626.2 | ENSP00000387266 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000479 AC: 12AN: 250428Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135396
GnomAD4 exome AF: 0.0000445 AC: 65AN: 1460330Hom.: 0 Cov.: 30 AF XY: 0.0000454 AC XY: 33AN XY: 726532
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152332Hom.: 0 Cov.: 33 AF XY: 0.0000805 AC XY: 6AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2023 | The c.1504A>G (p.K502E) alteration is located in exon 12 (coding exon 12) of the SPIRE1 gene. This alteration results from a A to G substitution at nucleotide position 1504, causing the lysine (K) at amino acid position 502 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at